<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041713/" ref="ordinalpos=885&amp;ncbi_uid=6186547&amp;link_uid=PMC4041713" image-link="/pmc/articles/PMC4041713/figure/F4/" class="imagepopup">Figure 4. DE-miRNAs identified in PBMCs from sarcoidosis patients are predicted to target the TGFβ/WNT molecular <span class="highlight" style="background-color:">pathway</span>.  From: Differential Expression of MicroRNA and Predicted Targets in Pulmonary Sarcoidosis. </a></div><br /><div class="p4l_captionBody">DIANA-mirPath was used to predict the most likely molecular pathways targeted by PCR-validated DE-miRNAs in sarcoidosis PBMCs and identified the TGFβ/WNT pathway as the most likely candidate. The arrows represent activation, whereas the hammerheads represent inhibition. The molecular components of the WNT signaling pathway and their putative interactions were derived from the KEGG pathway database.</div></div>